EHC Logo

Encompass Health Corp (EHC) Stock Forecast & Price Prediction

Live EHC Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Care Facilities

$98.63

-1.23 (-1.23%)

12 Month Price Forecast For EHC

$98.63
Current Price
$10.02B
Market Cap
13 Ratings
Buy 13
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to EHC Price Forecasts

+26.7%
To High Target of $125.00
+19.6%
To Median Target of $118.00
+11.5%
To Low Target of $110.00

EHC Price Momentum

-2.5%
1 Week Change
+8.3%
1 Month Change
+35.2%
1 Year Change
+6.8%
Year-to-Date Change
-5.7%
From 52W High of $104.55
+36.3%
From 52W Low of $72.38

๐Ÿค” Considering Encompass Health (EHC)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 6:53 AM UTC

EHC Analyst Ratings & Price Targets

Based on our analysis of 19 Wall Street analysts, EHC has a bullish consensus with a median price target of $118.00 (ranging from $110.00 to $125.00). The overall analyst rating is Strong Buy (9.7/10). Currently trading at $98.63, the median forecast implies a 19.6% upside. This outlook is supported by 13 Buy, 0 Hold, and 0 Sell ratings.

Conversely, the most conservative target is provided by Ben Hendrix at RBC Capital, suggesting a 11.5% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

EHC Analyst Consensus

13
Buy
0
Hold
0
Sell

EHC Price Target Range

Low
$110.00
Average
$118.00
High
$125.00
Current: $98.63

Latest EHC Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for EHC.

Date Firm Analyst Rating Change Price Target
Feb 10, 2025 Keybanc Matthew Gillmor Overweight Maintains $120.00
Feb 7, 2025 Barclays Andrew Mok Overweight Maintains $118.00
Oct 30, 2024 Truist Securities David Macdonald Buy Reiterates $116.00
Oct 30, 2024 RBC Capital Ben Hendrix Outperform Maintains $110.00
Oct 29, 2024 Keybanc Matthew Gillmor Overweight Maintains $117.00
Oct 29, 2024 Barclays Andrew Mok Overweight Maintains $116.00
Oct 14, 2024 Truist Securities David Macdonald Buy Maintains $108.00
Oct 11, 2024 Keybanc Matthew Gillmor Overweight Initiates $115.00
Sep 26, 2024 RBC Capital Ben Hendrix Outperform Maintains $105.00
Sep 25, 2024 UBS Andrew Mok Buy Maintains $110.00
Aug 15, 2024 Truist Securities David Macdonald Buy Maintains $104.00
Aug 8, 2024 UBS Andrew Mok Buy Maintains $100.00
Aug 6, 2024 Stephens & Co. Scott Fidel Overweight Reiterates $105.00
Aug 6, 2024 Barclays Andrew Mok Overweight Maintains $109.00
Jul 15, 2024 Truist Securities David Macdonald Buy Maintains $100.00
Jul 10, 2024 Leerink Partners Whit Mayo Outperform Initiates $100.00
Jul 10, 2024 Barclays Andrew Mok Overweight Maintains $113.00
Jun 5, 2024 Stephens & Co. Scott Fidel Overweight Reiterates $94.00
May 22, 2024 RBC Capital Ben Hendrix Outperform Maintains $95.00
Apr 26, 2024 Raymond James John Ransom Strong Buy Reiterates $95.00

Stocks Similar to Encompass Health Corp

The following stocks are similar to Encompass Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Encompass Health Corp (EHC) Financial Data

Encompass Health Corp has a market capitalization of $10.02B with a P/E ratio of 22.2x. The company generates $5.22B in trailing twelve-month revenue with a 8.1% profit margin.

Revenue growth is +11.9% quarter-over-quarter, while maintaining an operating margin of +15.5% and return on equity of +22.9%.

Valuation Metrics

Market Cap $10.02B
Enterprise Value $13.35B
P/E Ratio 22.2x
PEG Ratio 20.8x
Price/Sales 1.9x

Growth & Margins

Revenue Growth (YoY) +11.9%
Gross Margin +95.5%
Operating Margin +15.5%
Net Margin +8.1%
EPS Growth +26.8%

Financial Health

Cash/Price Ratio +1.5%
Current Ratio 1.0x
Debt/Equity 102.7x
ROE +22.9%
ROA +8.4%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Encompass Health Corp logo

Encompass Health Corp (EHC) Company Overview

About Encompass Health Corp

What They Do

Provides post-acute healthcare services.

Business Model

The company operates inpatient rehabilitation hospitals that deliver specialized medical, nursing, therapy, and ancillary services to patients recovering from physical or cognitive disabilities. It generates revenue primarily through the Medicare program, managed care plans, private insurers, and state governments, ensuring a diversified income stream from various healthcare payers.

Additional Information

Encompass Health Corporation, formerly known as HealthSouth Corporation, has been operating since 1984 and is headquartered in Birmingham, Alabama. Its focus on rehabilitation services positions it well within the healthcare sector, catering to a growing demand for post-acute care solutions.

Company Information

Sector

Healthcare

Industry

Medical Care Facilities

Employees

27,481

CEO

Mr. Mark J. Tarr

Country

United States

IPO Year

2017

Encompass Health Corp (EHC) Latest News & Analysis

EHC stock latest news image
Quick Summary

Encompass Health Corporation will hold its Q4 2024 Earnings Conference Call on February 7, 2024, at 10:00 AM ET, featuring key executives and several financial analysts.

Why It Matters

The earnings call provides insights into Encompass Health's financial performance, informing market expectations and influencing stock valuations, crucial for investment decisions.

Source: Seeking Alpha
Market Sentiment: Neutral
EHC stock latest news image
Quick Summary

Encompass Health Corporation (NYSE: EHC) announced Q4 2024 operational results on February 6, 2025. Further details on financial performance were not included in the excerpt.

Why It Matters

Encompass Health's Q4 2024 results can impact stock performance, indicating financial health, growth potential, and operational efficiency, which are critical for investment decisions.

Source: PRNewsWire
Market Sentiment: Neutral
EHC stock latest news image
Quick Summary

Encompass Health (EHC) reported Q3 earnings of $1.17 per share, surpassing estimates of $1.02 and up from $0.95 per share year-over-year.

Why It Matters

Encompass Health's stronger-than-expected earnings indicate robust financial health and growth, potentially boosting investor confidence and stock performance.

Source: Zacks Investment Research
Market Sentiment: Positive
EHC stock latest news image
Quick Summary

Encompass Health (EHC) reported its revenue and EPS for Q4 2024, highlighting the need to compare these figures with Wall Street estimates and previous year's performance.

Why It Matters

Comparison of Encompass Health's revenue and EPS against Wall Street estimates and prior year figures can indicate growth trends and market performance, influencing stock valuation and investor sentiment.

Source: Zacks Investment Research
Market Sentiment: Positive
EHC stock latest news image
Quick Summary

Encompass Health Corp. (NYSE: EHC) has been recognized in Fortune's 2025 World's Most Admired Companies list, highlighting its status in the rehabilitation hospital sector.

Why It Matters

Encompass Health's inclusion in Fortune's Most Admired Companies enhances its reputation, potentially attracting investors and boosting stock performance due to increased confidence in its management and operations.

Source: PRNewsWire
Market Sentiment: Neutral
EHC stock latest news image
Quick Summary

Encompass Health (EHC) is expected to report its Q4 2024 performance, with a focus on key metrics beyond traditional revenue and earnings estimates for deeper analysis.

Why It Matters

Analyzing Encompass Health's performance beyond traditional estimates can reveal underlying growth trends and operational efficiencies, influencing investment decisions and stock valuation.

Source: Zacks Investment Research
Market Sentiment: Neutral

Frequently Asked Questions About EHC Stock

What is Encompass Health Corp's (EHC) stock forecast for 2025?

Based on our analysis of 19 Wall Street analysts, Encompass Health Corp (EHC) has a median price target of $118.00. The highest price target is $125.00 and the lowest is $110.00.

Is EHC stock a good investment in 2025?

According to current analyst ratings, EHC has 13 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $98.63. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for EHC stock?

Wall Street analysts predict EHC stock could reach $118.00 in the next 12 months. This represents a 19.6% increase from the current price of $98.63. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Encompass Health Corp's business model?

The company operates inpatient rehabilitation hospitals that deliver specialized medical, nursing, therapy, and ancillary services to patients recovering from physical or cognitive disabilities. It generates revenue primarily through the Medicare program, managed care plans, private insurers, and state governments, ensuring a diversified income stream from various healthcare payers.

What is the highest forecasted price for EHC Encompass Health Corp?

The highest price target for EHC is $125.00 from at , which represents a 26.7% increase from the current price of $98.63.

What is the lowest forecasted price for EHC Encompass Health Corp?

The lowest price target for EHC is $110.00 from Ben Hendrix at RBC Capital, which represents a 11.5% increase from the current price of $98.63.

What is the overall EHC consensus from analysts for Encompass Health Corp?

The overall analyst consensus for EHC is bullish. Out of 19 Wall Street analysts, 13 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $118.00.

How accurate are EHC stock price projections?

Stock price projections, including those for Encompass Health Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.